semaglutide and tylenol The letter cited three deaths among patients using semaglutide, the active ingredient in several of its weight-loss medications, which it said were not properly investigated or reported. Read more at the link A new study says semaglutide

Despite a small detectable increase in birth weight of newborns from GLP-1-exposed pregnancies, there was no increased risk of large or small for gestational age birth weight or cesarean delivery associated with pre-pregnancy or early pregnancy GLP-1 use, Maya and colleagues wrote

This can increase the risk of malnutrition, which is more common for older adults than many people realize

Bookmark this page for regular reference because dosing guidelines are updated as new clinical data becomes available

Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat: pooled analysis of two multicenter Phase 3 trials with safety extension data

1, alkaline (Na 2 CO 3 ) treatment induced yellowing symptoms on maize leaves

Tirzepatide (Dual Receptor) Mounjaro FDA-approved for type 2 diabetes Zepbound FDA-approved for obesity Tirzepatide activates two receptors: GLP-1 and GIP